These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 1967118)

  • 1. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
    Chambers LA; Kruskall MS; Pacini DG; Donovan LM
    Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W; Tormey CA; Capetillo A; Maitta RW
    Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions.
    Mangano MM; Chambers LA; Kruskall MS
    Am J Clin Pathol; 1991 May; 95(5):733-8. PubMed ID: 2024629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
    Wang RR; Triulzi DJ; Qu L
    Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
    Klüter H; Bubel S; Kirchner H; Wilhelm D
    Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
    Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
    Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
    Daurat A; Roger C; Gris J; Daurat G; Feissel M; Le Manach Y; Lefrant J; Muller L
    Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
    McFarland JG; Anderson AJ; Slichter SJ
    Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
    Muylle L; Wouters E; Peetermans ME
    Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single donor versus pooled random donor platelet concentrates.
    Ness PM; Campbell-Lee SA
    Curr Opin Hematol; 2001 Nov; 8(6):392-6. PubMed ID: 11604581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-donor platelets reduce the risk of septic platelet transfusion reactions.
    Ness P; Braine H; King K; Barrasso C; Kickler T; Fuller A; Blades N
    Transfusion; 2001 Jul; 41(7):857-61. PubMed ID: 11452152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO-incompatible platelets are associated with increased transfusion reaction rates.
    Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
    Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing transfusion reactions between pre-storage and post-storage leukoreduced apheresis platelets: an analysis using propensity score matching.
    Chien SH; Huang HY; Chen YJ; Tsai YC; Lu SH; Lee LH; Liu HM; Chen WC; Liu YC; Lin TA; Liu CY
    Ann Hematol; 2024 Apr; 103(4):1389-1396. PubMed ID: 38393657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.